Opana ER was formulated to deter or prevent abuse, with a crush-proof coating that reduced addicts’ ability to inhale or “snort” the drug. However, through grating and dissolving the new coated pills, drug abusers found the medication—originally designed to provide pain relief for patients with chronic, severe, long-term pain—was now injectable, leading to a quicker…

The number of former Insys Therapeutics employees who are pleading guilty to criminal charges is increasing. A Reuters release (provided via CNBC) said that Natalie Levine and Karen Hill, “Two former Insys Therapeutics Inc sales representatives… pleaded guilty on Tuesday to engaging in schemes to pay kickbacks to medical practitioners to prescribe a drug containing…

This month, news broke that Insys Therapeutics, the makers of the fentanyl-based opioid spray Subsys were in talks with the U.S. Department of Justice to resolve their probe into the company and its predatory practices. As the country tries to mitigate its overdose and addiction crisis – much of which is perpetuated by prescription opioid…

Insys Therapeutics, makers of the fentanyl spray Subsys, is facing considerable pressure from authorities for their deceptive marketing practices, which could be linked to a number of opioid-related overdoses throughout the country. McGowan, Hood, Felder & Phillips, LLC, has been aggressively pursuing justice on behalf of Subsys patients, and their families, who have been wrongfully…